Appen Ltd (APX)
Australian Securities Exchange · Australia · prices in AUD · close of 23 Oct 2026
Key indicators
| Last close | AUD 1.060 |
|---|---|
| 52-week range | 0.650 – 1.975 |
| Return, 1 month / 3 months | −13.1% / +18.4% |
| Return, 1 year / 3 years | +38.6% / +20.2% |
| Trend | Below its 200-day average |
| RSI (14) | 47 |
| Volatility (1 year) | 95.2% |
| Worst drawdown (1 year) | -56.8% |
| Average daily value traded | 3.53M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Appen Ltd provides training data and related services that help organisations build and improve machine learning and artificial intelligence systems. Its work includes collecting and annotating images, text, audio and video, along with transcription and language services, carried out by a large network of contractors. Customers include technology companies and other organisations that develop artificial intelligence products. The company is based in Australia and operates internationally, supporting clients across many languages and markets.
The shares are listed on the Australian Securities Exchange in Australia under the code APX, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Appen Ltd (APX) trades on the Australian Securities Exchange in Australia. It last closed at AUD 1.060 on 23 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 738 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 38.6% and over the last three months it rose 18.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 48 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -16.2% | ||
| From 52-week high | -44.2% | ||
| Momentum | 70 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 18.4% | ||
| 6-month return | -34.6% | ||
| 12-month return, skipping the last month | 59.5% | ||
| Stability (higher is calmer) | 36 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 95.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -56.8% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 3.53M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +5.5% |
|---|---|
| 1 month | −13.1% |
| 3 months | +18.4% |
| 6 months | −34.6% |
| 1 year | +38.6% |
| 3 years | +20.2% |
| 5 years | −89.0% |
Signals
| 50-day / 200-day average | 1.152 / 1.265 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.064 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Mar 2022 | AUD 0.0486 |
| 31 Aug 2021 | AUD 0.0398 |
| 1 Mar 2021 | AUD 0.0486 |
| 1 Sep 2020 | AUD 0.0398 |
| 28 Feb 2020 | AUD 0.0442 |
| 3 Sep 2019 | AUD 0.0354 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.